A new study published in the journal Immunity reveals a mechanism that allows triple negative breast cancer (TNBC) to develop resistance to therapy.

A phase 1 trial has reported positive safety findings of SON-1010 among patients with advanced leiomyosarcoma (LMS) or ...

A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first ...

Dr. Rebecca Lewis and staff are amazing. Everyone treated us with compassion, and were so kind and gentle with Roxi. She ...

Questions the vet will ask: The vet will usually remove some cells from the lump with a fine needle in order to examine them ...

What drew you to pursue a career in oncology and what is it that inspires you most about working in this field?

Last year, the hospital’s former superintendent Kao Mao-jen (高茂仁) and veterinarian Hung Yi-ping (洪一平) were convicted of ...

A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

A cancer drug developed ten years ago at UCSF can also put the brakes on one of prostate cancer's deadliest molecular tricks.

Cancer is one of the leading causes of death in dogs, with diagnosis ranging from lymphoma to mast cell tumors. A recent trend in pet care among owners is ...

The global mast cell tumor treatment market is on a strong growth trajectory, with market projections estimating a valuation of USD 7,836.4 million by 2034. This reflects a steady CAGR of 3.4% from ...

State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), ChemBioMed Interdisciplinary Research Center, ...